Obesity is a recognized breast cancer risk factor in postmenopausal women. A recent hypothesis suggests a major role for adipose tissue in carcinogenesis. During many years, the adipose tissue was only considered as a fat storage of energy. This tissue is now described as an endocrine organ secreting a large range of molecules called adipokines. Among these adipokines, adiponectin may play a major role in breast cancer. Plasma adiponectin levels were found to be decreased in cases of breast cancer and in obese patients. Adiponectin may act directly on breast cancer cells by inhibiting proliferation and angiogenesis or by stimulating apoptosis. Increasing adiponectin levels may be of major importance in the prevention and/or the treatment of breast cancer. This therapeutic approach may be of particular significance for obese patients. The beneficial effects of adiponectin and its possible therapeutic applications will be discussed in this review.
|Title of host publication||Vitamins & Hormones|
|Place of Publication||USA|
|Pages||397 - 417|
|Number of pages||21|
|Publication status||Published - 2012|
Delort, L., Jarde, T., Dubois, V., Vasson, M-P., & Caldefie-Chezet, F. (2012). New insights into anticarcinogenic properties of adiponectin: a potential therapeutic approach in breast cancer? In G. Litwack (Ed.), Vitamins & Hormones (1st ed., pp. 397 - 417). Elsevier. https://doi.org/10.1016/B978-0-12-398313-8.00015-4